新型糖电解质输液在外科液体治疗的应用  

Application of New Glucose and Electrolyte Infusion in Surgical Liquid Treatment

作　　者：孙忠实[1] 朱明炜[2] 

机构地区：[1]解放军海军总医院,北京100048 [2]北京医院普外科,北京100730

出　　处：《中国医院用药评价与分析》2016年第2期145-148,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：液体治疗的进步是伴随着对人体体液代谢病理生理机制认识的深入、输液产品的开发和临床监测手段的完善而发展的。体液容量、渗透压及电解质含量是维持机体正常代谢、内环境稳定和各器官功能的基本保证。外科患者由于疾病、禁食、手术创伤等原因导致体液平衡失调而需要进行合理的液体治疗。为此,合理选择液体的种类、剂量,有效地维持体/微循环的稳定,保证组织器官功能的正常运转,降低围术期并发症的发生率,对改善患者的预后极为重要。目前,常用的液体治疗药物主要有晶体液和胶体液两大类。近年来,晶体液中以混合糖电解质为代表的新型糖电解质输液得到了快速发展,是临床补液治疗的基础药物之一。本文就外科液体治疗的目的、相关理论、具体方案和新型糖电解质输液的临床应用进行综述。OBJECTIVE： The progress of liquid treatment is developing with the accompany of the deep understanding of the body fluid metabolism pathological physiological mechanism,research of infusion products and improvement of the clinical monitoring means. Fluid capacity,osmotic pressure and electrolyte content are the basic guarantee for maintaining matter metabolism,stable internal environment and physiological function in human body.The surgical patients were suppose to get rational fluid therapy for the disorder of body fluid balance caused by disease,fasting and surgical trauma,etc. Therefore,it is important to improve the prognosis of patients by the rational selection of types and dosage,the effective maintaining of systemic circulation and microcirculation,the normal operation of organ function and the reduction of incidence of perioperative complications. At present,the commonly used liquid are liquid crystal and colloid. Carbohydrate and electrolyte injection as one of the basic drugs for liquid treatment in clinic,on behalf of crystal infusion of new glucose electrolyte solution,developed rapidly in recent years. This thesis aims to review the purpose,the related theories,concrete proposal of surgical liquid treatment and the clinical application of new glucose and electrolyte infusion.

关 键 词：新型糖电解质输液 外科液体治疗 混合糖电解质 

分 类 号：R977[医药卫生—药品]